BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15887288)

  • 1. RASSF1A promoter methylation and 3p21.3 loss of heterozygosity are features of foregut, but not midgut and hindgut, malignant endocrine tumours.
    Pizzi S; Azzoni C; Bottarelli L; Campanini N; D'Adda T; Pasquali C; Rossi G; Rindi G; Bordi C
    J Pathol; 2005 Aug; 206(4):409-16. PubMed ID: 15887288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine tumours of the gastrointestinal tract: aetiology, molecular pathogenesis and genetics.
    Rindi G; Bordi C
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):519-34. PubMed ID: 16183525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma.
    Lázcoz P; Muñoz J; Nistal M; Pestaña A; Encío I; Castresana JS
    BMC Cancer; 2006 Oct; 6():254. PubMed ID: 17064406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer.
    Ito M; Ito G; Kondo M; Uchiyama M; Fukui T; Mori S; Yoshioka H; Ueda Y; Shimokata K; Sekido Y
    Cancer Lett; 2005 Jul; 225(1):131-9. PubMed ID: 15922865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma.
    Wong ML; Tao Q; Fu L; Wong KY; Qiu GH; Law FB; Tin PC; Cheung WL; Lee PY; Tang JC; Tsao GS; Lam KY; Law S; Wong J; Srivastava G
    Int J Oncol; 2006 Mar; 28(3):767-73. PubMed ID: 16465383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignancy-associated allelic losses on the X-chromosome in foregut but not in midgut endocrine tumours.
    Pizzi S; D'Adda T; Azzoni C; Rindi G; Grigolato P; Pasquali C; Corleto VD; Delle Fave G; Bordi C
    J Pathol; 2002 Apr; 196(4):401-7. PubMed ID: 11920735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation of the RASSF1A gene in gliomas.
    Gao Y; Guan M; Su B; Liu W; Xu M; Lu Y
    Clin Chim Acta; 2004 Nov; 349(1-2):173-9. PubMed ID: 15469871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis.
    Peters I; Rehmet K; Wilke N; Kuczyk MA; Hennenlotter J; Eilers T; Machtens S; Jonas U; Serth J
    Mol Cancer; 2007 Jul; 6():49. PubMed ID: 17634119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status of RASSF1A in uveal melanocytes and melanoma cells.
    Calipel A; Abonnet V; Nicole O; Mascarelli F; Coupland SE; Damato B; Mouriaux F
    Mol Cancer Res; 2011 Sep; 9(9):1187-98. PubMed ID: 21788308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenomatous polyposis coli alteration in digestive endocrine tumours: correlation with nuclear translocation of beta-catenin and chromosomal instability.
    Pizzi S; Azzoni C; Tamburini E; Bottarelli L; Campanini N; D'Adda T; Fellegara G; Luong TV; Pasquali C; Rossi G; Delle Fave G; Camisa R; Bordi C; Rindi G
    Endocr Relat Cancer; 2008 Dec; 15(4):1013-24. PubMed ID: 18632876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
    Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
    Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas.
    Hesson L; Bièche I; Krex D; Criniere E; Hoang-Xuan K; Maher ER; Latif F
    Oncogene; 2004 Mar; 23(13):2408-19. PubMed ID: 14743209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma.
    Dammann R; Schagdarsurengin U; Liu L; Otto N; Gimm O; Dralle H; Boehm BO; Pfeifer GP; Hoang-Vu C
    Oncogene; 2003 Jun; 22(24):3806-12. PubMed ID: 12802288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiposity and age are statistically related to enhanced RASSF1A tumor suppressor gene promoter methylation in normal autopsy kidney tissue.
    Peters I; Vaske B; Albrecht K; Kuczyk MA; Jonas U; Serth J
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2526-32. PubMed ID: 18086755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
    Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent hypermethylation of RASSF1A in early flat-type colorectal tumors.
    Sakamoto N; Terai T; Ajioka Y; Abe S; Kobayasi O; Hirai S; Hino O; Watanabe H; Sato N; Shimoda T; Fujii H
    Oncogene; 2004 Nov; 23(55):8900-7. PubMed ID: 15480433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma.
    Geli J; Kiss N; Lanner F; Foukakis T; Natalishvili N; Larsson O; Kogner P; Höög A; Clark GJ; Ekström TJ; Bäckdahl M; Farnebo F; Larsson C
    Endocr Relat Cancer; 2007 Mar; 14(1):125-34. PubMed ID: 17395981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant methylation of RASGRF2 and RASSF1A in human non-small cell lung cancer.
    Chen H; Suzuki M; Nakamura Y; Ohira M; Ando S; Iida T; Nakajima T; Nakagawara A; Kimura H
    Oncol Rep; 2006 May; 15(5):1281-5. PubMed ID: 16596198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
    Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
    Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.